Accepted for/Published in: JMIR Formative Research
Date Submitted: May 30, 2023
Open Peer Review Period: May 30, 2023 - Jul 21, 2023
Date Accepted: Aug 15, 2023
(closed for review but you can still tweet)
A health app platform providing a budget to purchase preselected apps as an innovative way to support public health?: A qualitative study with end-users and other stakeholders
ABSTRACT
Background:
eHealth has the potential to improve health outcomes. However, this potential is largely untapped. Individuals face an overload of apps and have difficulties choosing suitable apps for themselves. In the FitKnip experiment, individuals were given access to a health app platform, where they could purchase reliable preselected health apps with a personal budget of 100 euros.
Objective:
The aim of this study was to scientifically evaluate the health app platform as an innovative way to improve population health on concept, feasibility, acceptability, perceived impact on health, and health empowerment.
Methods:
This study included seven focus group interviews with end-users and one with stakeholders. All focus groups were semi-structured using interview guides. The analyses were conducted according to the principles of the Framework Method. Identified themes were concept, acceptability, health empowerment and outcomes, and future implementation.
Results:
Both end-users and stakeholders were enthusiastic about the concept of a health app platform. End-users indicated missing apps regarding physical health and lifestyle and needing more guidance towards suitable apps. End-users and stakeholders identified potential providers of FitKnip. Stakeholders suggested a trusted National quality mark to show FitKnip and the provided apps are safe.
Conclusions:
This study showed the need for a personalized and flexible platform. Next to this, a deeper understanding of the roles of stakeholders in such initiatives is needed especially on financing and reimbursement of health promotion and digital health services. A health app platform is a promising innovative initiative to enhance public health. Clinical Trial: The FitKnip study was declared to not fall within the scope of the Dutch Medical Research Involving Human Subjects Act by the medical ethics committee of Leiden, Den Haag, Delft (N19.0878).
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.